Swedbank Ab Zai Lab LTD Transaction History

Swedbank Ab

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 21, 2024	BUY	$15.95 - $26.8 $242,440 - $407,360	15,200 New	15,200 $244 Million
Q4 2023 Dec 09, 2024	BUY	$22.97 - $30.58 $236,591 - $314,974	10,300 Added 80.47%	23,100 $631,000
Q1 2022 Dec 09, 2024	SELL	$27.77 - $64.4 $2 Million - $4.64 Million	-72,000 Reduced 84.91%	12,800 $562,000
Q1 2021 Dec 09, 2024	BUY	$126.27 - $191.71 $10.7 Million - $16.3 Million	84,800 New	84,800 $11.3 Million

123

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.55B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

Stay updated on Swedbank Ab with notifications on news.